Uterine Fibroid Treatment Devices Market by Technology (Ablation, Hysterectomy, Myomectomy Laparoscopy, Microwave, Cryoablation, HIFU, MRgFUS, Myolysis, Embolization), Mode of Treatment (Invasive, Minimally Invasive, Non-Invasive), Region (North America, Europe, Asia Pacific, South America, Middle East and Africa), and Global trends and forecast from 2022 to 2029

Published on: Apr 2022
From:USD $3499.00
Number Of Pages:116

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 10.5 billion	9.1%	North America

by Technology	by Mode	by Region
Surgical Techniques Hysterectomy Myomectomy Laparoscopic Techniques Laparoscopic Myomectomy Myolysis Ablation Techniques Microwave Ablation Hydrothermal Ablation Cryoablation Ultrasound Ablation High Intensity Focused Ultrasound (Hifu) Mri-Guided Focused Ultrasound (Mrgfus) Other Ablation Techniques Embolization Techniques	Invasive Treatment Minimally Invasive Treatment Non-Invasive Treatment	North America Europe Asia Pacific South America Middle East And Africa

5/5 - (11 votes)

Uterine Fibroid Treatment Devices Market Overview

The global uterine fibroid treatment devices market is expected to grow at 9.1% CAGR from 2022 to 2029. It is expected to reach above USD 10.5 billion by 2029 from USD 4.8 billion in 2020.

The global prevalence of uterine fibroids among women, coupled with an increasing preference for minimally invasive procedures and the adoption of advanced technologies, are expected to be the primary drivers of market growth. Uterine fibroids, benign tumors of smooth muscle cells within the uterus, can lead to various symptoms including excessive menstrual bleeding, pelvic pain, infertility, and frequent urination. Although the exact cause remains unknown, risk factors such as race, age, familial predisposition, premenopausal status, hypertension, overweight, and diet have been identified. Despite the fact that 50 to 75% of uterine fibroid cases are asymptomatic and receive less clinical attention, they often go undiagnosed.

Countries like the United States and Canada have experienced a rise in uterine fibroid cases and subsequent surgeries in recent years. In the U.S., uterine fibroids are the leading reason for hysterectomies, accounting for 39% of all hysterectomies performed annually. Additionally, according to the American Journal of Obstetrics & Gynecology, over one-third of hysterectomies in the U.S. are performed due to uterine fibroids. Similarly, the Journal of Obstetrics & Gynecology Canada (JOGC) reports over 41,000 hysterectomies performed each year in Canada. The necessity for uterine fibroid treatment devices to perform such procedures is expected to drive market growth in the forecast period.

Uterine Fibroid Treatment Devices Market | Exactitude Consultancy

Furthermore, the increasing prevalence of uterine fibroid-related disorders in both developed and developing countries has spurred the introduction of technologically advanced products in the market. For example, Channel Medsystem’s Cerene Cryotherapy device effectively treats heavy menstrual bleeding by using extreme cold to destroy uterine tissue lining, eliminating the need for general anesthesia. Additionally, Insightec’s MR-guided Focused Ultrasound (MRgFUS) offers an incisionless procedure for uterine fibroid treatment, utilizing ultrasound beams to heat and remove targeted tissue from the uterine cavity.

Uterine Fibroid Treatment Devices Market Segment Analysis

The uterine fibroid treatment devices market is segmented into product technology, mode of treatment, and region.

On the basis of technology, the market is segmented into the market is segmented into surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. The surgical techniques segment dominated the overall market with a highest share percent. This is due to an increase in the number of hysterectomy and myomectomy surgical procedures, which are the most commonly performed procedures for the treatment of fibroids in women. Furthermore, this technique is the most popular and well-proven permanent solution for uterine fibroids treatment. As a result, an increase in the number of related surgeries is expected to drive segment growth.

The ablation techniques segment is expected to grow at the fastest CAGR compare to other. This is a minimally invasive procedure that surgically ablates the uterine endometrium lining. This is a common surgical procedure used to treat heavy menstrual bleeding. Endometrial ablation requires no incisions and can be performed in the doctor’s office without the use of general anaesthesia. Furthermore, pregnancy is possible following endometrial ablation. As a result, the advantages provided by ablation techniques are expected to drive segment growth.

On the basis of mode of treatment, the market is segmented into invasive, minimally invasive, and non-invasive treatment. The invasive treatment segment held a highest share of the overall market. This is due to an increase in uterine fibroids and associated symptoms in women all over the world. Abdominal myomectomy and hysterectomy are gold-standard procedures for the treatment of uterine fibroids and have gained widespread acceptance due to their low cost. As a result, these factors are expected to boost demand for uterine fibroids treatment devices.

The non-invasive treatment segment is expected to grow at the fastest CAGR compare to other. This is due to an increase in the demand for incisionless procedures for related disorders. The main advantage of such procedures is the small size of the incision; unlike traditional surgeries, which use large openings, minimally invasive procedures use small openings. As a result of these factors, demand for uterine fibroids treatment devices is expected to rise.

Uterine Fibroid Treatment Devices Market Players

The key players operating in the uterine fibroid treatment devices market across the globe are Advanced Surgical Concepts, PLLC (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), Medtronic, Stryker, CooperSurgical, Inc. (U.S.), Ethicon, Inc. (U.S.), Hologic, Inc. (U.S.), Medtronic, Plc (U.S.), Olympus Corporation (Japan), PENTAX Medical (Japan), and Stryker Corporation (U.S.), among others.

Who Should Buy? Or Key Stakeholders

Medical devices manufacturing companies.
Healthcare companies.
Government and research organizations
Investment research firms

Key Takeaways

The global uterine fibroid treatment devices market is expected to grow at 9.1% CAGR
Based on End-user industry, Cosmetics is expected to dominate the segment.
On the basis of technology, the surgical techniques segment dominated the overall market with a highest share percent.
North America dominated the market with a 42 percent share.
Minimally invasive procedures are emerging as a prominent trend in the Uterine Fibroid Treatment Devices Market.

Uterine Fibroid Treatment Devices Market Regional Analysis

The uterine fibroid treatment devices market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America dominated the market with a 42 percent share. This is due to the region’s well-established healthcare facilities, rising government initiatives, and an increase in hysterectomy-related surgical procedures/hospital visits. Furthermore, the presence of major key players such as Medtronic, Stryker, and CooperSurgical, Inc., as well as the availability of technologically advanced products, are contributing to the region’s market growth. Furthermore, the region’s adoption of uterine fibroids treatment devices is being driven by the ease of access to healthcare technologies and the presence of strong distribution channels.

Key Market Segments: Uterine Fibroid Treatment Devices Market

Uterine Fibroid Treatment Devices Market by Technology, 2020-2029, (USD Million)

Surgical Techniques
- Hysterectomy
- Myomectomy
Laparoscopic Techniques
- Laparoscopic Myomectomy
- Myolysis
Ablation Techniques
- Microwave Ablation
- Hydrothermal Ablation
- Cryoablation
- Ultrasound Ablation
  - High Intensity Focused Ultrasound (Hifu)
  - Mri-Guided Focused Ultrasound (Mrgfus)
- Other Ablation Techniques
Embolization Techniques

Uterine Fibroid Treatment Devices Market by Mode of Treatment, 2020-2029, (USD Million)

Invasive Treatment
Minimally Invasive Treatment
Non-Invasive Treatment

Uterine Fibroid Treatment Devices Market by Region, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important countries in all regions are covered.

Key Question Answered

What is the current size of the uterine fibroid treatment devices market?
What are the key factors influencing the growth of uterine fibroid treatment devices?
What are the major opportunities for existing players and new entrants in the market?
Who are the major key players in the uterine fibroid treatment devices market?
Which region will provide more business opportunities for uterine fibroid treatment devices in future?
Which segment holds the maximum share of the uterine fibroid treatment devices market?

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions and Limitations
Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources
Executive Summary
Market Overview
1. Global Fibroid Treatment Devices Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact of Covid-19 On Fibroid Treatment Devices Market
3. Porter’s five forces model
  1. Threat from new entrants
  2. Threat from substitutes
  3. Bargaining power of suppliers
  4. Bargaining power of customers
  5. Degree of competition
4. Industry value chain Analysis
Fibroid Treatment Devices Market by Technology
1. Surgical Techniques
  1. Hysterectomy
  2. Myomectomy
2. Laparoscopic Techniques
  1. Laparoscopic Myomectomy
  2. Myolysis
3. Ablation Techniques
  1. Microwave Ablation
  2. Hydrothermal Ablation
  3. Cryoablation
  4. Ultrasound Ablation
    1. High Intensity Focused Ultrasound (HIFU)
    2. MRI-guided Focused Ultrasound (MRgFUS)
  5. Other Ablation Techniques
4. Embolization Techniques
Fibroid Treatment Devices Market by Mode of Treatment
1. Invasive Treatment
2. Minimally Invasive Treatment
3. Non-invasive Treatment
Global Fibroid Treatment Devices Market, By Region
1. North America
  1. US
  2. Canada
  3. Mexico
2. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest Of South America
3. Europe
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest Of Europe
4. Asia Pacific
  1. India
  2. China
  3. Japan
  4. South Korea
  5. Australia
  6. South-East Asia
  7. Rest Of Asia Pacific
5. Middle East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest Of Middle East and Africa
Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
1. Advanced Surgical Concepts
2. Boston Scientific Corporation
3. Conmed Corporation
4. Coopersurgical, Inc.
5. Ethicon, Inc.
6. Hologic, Inc.
7. Medtronic, PLC.
8. Olympus Corporation
9. Pentax Medical
10. Stryker Corporation Thermo Fisher Scientific

*The Company List Is Indicative

LIST OF TABLES

TABLE 1 GLOBAL FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 2 GLOBAL FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 3 GLOBAL FIBROID TREATMENT DEVICES MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 4 US FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 5 US FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 6 CANADA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 7 CANADA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 8 MEXICO FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 9 MEXICO FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 10 BRAZIL FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 11 BRAZIL FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 12 ARGENTINA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 13 ARGENTINA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 14 COLOMBIA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 15 COLOMBIA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 16 REST OF SOUTH AMERICA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 17 REST OF SOUTH AMERICA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 18 INDIA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 19 INDIA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 20 CHINA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 21 CHINA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 22 JAPAN FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 23 JAPAN FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 24 SOUTH KOREA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 25 SOUTH KOREA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 26 AUSTRALIA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 27 AUSTRALIA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 28 SOUTH-EAST ASIA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 29 SOUTH-EAST ASIA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 30 REST OF ASIA PACIFIC FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 31 REST OF ASIA PACIFIC FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 32 GERMANY FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 33 GERMANY FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 34 UK FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 35 UK FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 36 FRANCE FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 37 FRANCE FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 38 ITALY FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 39 ITALY FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 40 SPAIN FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 41 SPAIN FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 42 RUSSIA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 43 RUSSIA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 44 REST OF EUROPE FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 45 REST OF EUROPE FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 46 UAE FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 47 UAE FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 48 SAUDI ARABIA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 49 SAUDI ARABIA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 50 SOUTH AFRICA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 51 SOUTH AFRICA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

TABLE 52 REST OF MIDDLE EAST AND AFRICA FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 53 REST OF MIDDLE EAST AND AFRICA FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL FIBROID TREATMENT DEVICES MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 9 GLOBAL FIBROID TREATMENT DEVICES MARKET BY MODE OF TREATMENT, USD MILLION, 2020-2029

FIGURE 10 GLOBAL FIBROID TREATMENT DEVICES MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 11 PORTER’S FIVE FORCES MODEL

FIGURE 12 NORTH AMERICA FIBROID TREATMENT DEVICES MARKET SNAPSHOT

FIGURE 13 EUROPE FIBROID TREATMENT DEVICES MARKET SNAPSHOT

FIGURE 14 ASIA PACIFIC FIBROID TREATMENT DEVICES MARKET SNAPSHOT

FIGURE 15 SOUTH AMERICA FIBROID TREATMENT DEVICES MARKET SNAPSHOT

FIGURE 16 MIDDLE EAST & AFRICA FIBROID TREATMENT DEVICES MARKET SNAPSHOT

FIGURE 17 ADVANCED SURGICAL CONCEPTS: COMPANY SNAPSHOT

FIGURE 18 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

FIGURE 19 CONMED CORPORATION: COMPANY SNAPSHOT

FIGURE 20 COOPERSURGICAL, INC.: COMPANY SNAPSHOT

FIGURE 21 ETHICON, INC.: COMPANY SNAPSHOT

FIGURE 22 HOLOGIC, INC.: COMPANY SNAPSHOT

FIGURE 23 MEDTRONIC, PLC.: COMPANY SNAPSHOT

FIGURE 24 OLYMPUS CORPORATION: COMPANY SNAPSHOT

FIGURE 25 PENTAX MEDICAL: COMPANY SNAPSHOT

FIGURE 26 STRYKER CORPORATION THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT